Repository logo
Government of Nepal
NEPAL HEALTH RESEARCH COUNCIL
Repository logo
  • Log In
    New user? Click here to register. Have you forgotten your password?
Repository logo
Government of Nepal
NEPAL HEALTH RESEARCH COUNCIL
Repository logo
  • Log In
    New user? Click here to register. Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Anand, A"

Now showing 1 - 2 of 2
Results Per Page
Sort Options
  • Loading...
    Thumbnail Image
    Publication
    Juvenile Generalized Myasthenia Gravis: Presented as Unilateral Blepharoptosis and Successfully Managed with Pulse Intravenous Methylprednisolone
    (Kathmandu University, 2021) Poudel, P; Anand, A; Ghosh, S
    ABSTRACT Myasthenia Gravis is a rare autoimmune disorder of childhood and this is rarer in South Asia. We present a pre-pubertal 7 year old female child of seropositive Generalized Juvenile Myasthenia Gravis. She presented with unilateral blepharoptosis and later generalized symptoms appeared. Ice-pack test, Neostigmine challenge test and acetylcholine receptor antibody test were positive. Serum muscle specific tyrosine kinase antibody test was normal. She did not have thymic abnormalities. She did not respond to high dose (26 mg/kg/day) of Pyridostigmine and oral Prednisolone (2 mg/kg/day), but was successfully treated with a combination of pulse intravenous Methylprednisolone (30 mg/kg once a month for 6 months) and daily doses of oral Prednisolone (2 mg/kg/day) along with Pyridostigmine without significant side effects. This combination can be considered a potential inexpensive treatment for Juvenile Myasthenia Gravis in a resource limited area where other immunosuppressive treatments such as intravenous immunoglobulin is expensive and unaffordable. KEY WORDS Blepharoptosis, Child, Methylprednisolone, Muscle weakness, Myasthenia gravis
  • Loading...
    Thumbnail Image
    Publication
    Malathion induced changes on hepatic acid and alkaline phosphatases in developing rats
    (Institute of Medicine, 2001) Seal, Reneta; Jha, B; Sen, P; Anand, A
    Abstract The effect of malathion, an organophosphorous pesticide, was assessed on the biochemical nature of the hepatic organ. Malathion was administered per os at doses of 5mg, 50mg, 250mg and 500mg/kg body weight at a time interval of 24 hours to developing rats of Charles Foster Strain. Enzyme activities, e.g. acid phosphates and alkaline phosphates estimated would indicate that malathion may induce possible cellularlysis and tissue degeneration at high doses during developing stage. Keywords: Malathion, acid phosphatases, alkaline phosphatases

Connect with us

Nepal Health Research Council © 2026
Ramshah Path, Kathmandu Nepal P.O.Box 7626